NSF International has acquired a majority interest in Amarex Clinical Research, LLC, a clinical stage contract research organization (CRO) headquartered in Germantown, MD. As part of NSF’s global health science consulting business, the CRO will be known as Amarex Clinical Research, LLC, an NSF International company. Amarex will gain access to NSF’s network and international scale and will continue to operate from its U.S. office. The company also operates an office in Taiwan and has a develop...